Impact of omalizumab therapy on medication requirements for chronic rhinosinusitis.

Chandra RK, Clavenna M, Samuelson M, Tanner SB, Turner JH
Int Forum Allergy Rhinol. 2016 6 (5): 472-7

PMID: 26679299 · DOI:10.1002/alr.21685

MeSH Terms (14)

Adrenal Cortex Hormones Adult Anti-Allergic Agents Anti-Asthmatic Agents Anti-Bacterial Agents Chronic Disease Drug Utilization Female Humans Male Middle Aged Omalizumab Rhinitis Sinusitis

Connections (1)

This publication is referenced by other Labnodes entities:

Links